Cognition Therapeutics Inc.(NASDAQ:CGTX) 
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 recept...
Website: http://www.cogrx.com
Founded: 2007
CEO: Hank Safferstein
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.39
H 0.39
L 0.34
C 0.35
V 975,528
10EMA 0.35
20EMA 0.35
60EMA 0.35
120EMA 0.35
250EMA 0.35